Tag Archives for " episode 274 "
Would you like to train with Allan? I'm going to take on one or two more clients for one-on-one training. One-on-one online training, customized programming, nutrition advice, weekly check in calls, and much more. Go to https://40plusfitnesspodcast.com/application.
Dr. Dale Bredesen is the author of the eye-opening new book entitled The End of Alzheimer’s: The First Program to Prevent and Reverse Cognitive Decline. The book details Alzheimer’s as a disease on the rise. The most common cause of dementia, Alzheimer’s is the number one health concern of individuals as we age, as there is no known treatment.
Today, Alzheimer’s is presenting even earlier among those in their late 40s and early 50s. But what is Alzheimer’s? Dr. Bredesen describes the disease as a dementing illness in which people progressively lose cognition. Many may begin by losing new memories. Some may first lose the ability to organize, speak, or read. Eventually, those affected will lose the ability to perform all of these functions.
Dr. Bredesen discusses the three types of Alzheimer’s. The first type is one that is caused by chronic inflammation as part of the body’s immune response. Type two, or atrophic or cold Alzheimer’s, is characterized by the inability to learn new things. The third type of Alzheimer’s is due to exposure to chemical, bio, or physical toxins which can predispose individuals to the disease. Dr. Bredesen also discusses the link between diabetes and Alzheimer’s. Though diabetes is a common contributor to Alzheimer’s, there is much more to the disease than just this aspect.
Dr. Bredesen explains that the goal is to make Alzheimer’s a rare disease. This can be accomplished through preventing the disease, improving cognition, and reducing cognitive decline. Monotherapies have not worked for chronic, complex illnesses such as Alzheimer’s. As such, Dr. Bredesen discusses a computer-based algorithm that will look at 150 different drivers of cognitive decline, evaluate these, and determine what is actually causing one’s cognitive decline on an individual level. This also provides a personalized strategy and optimized outcomes.